Company intelligence / Profile preview

VAP Diagnostics Lab

Birmingham, Alabama, United States

Ownership: Private
Employees: ~35
Development stage: Other

Overview

VAP Diagnostics Lab is a clinical reference laboratory specializing in cardiometabolic health diagnostics, particularly advanced cholesterol testing using the VAP+ lipid panel for heart disease risk assessment. The company was founded in 2016, acquiring technology from the bankrupt Atherotech Diagnostics Lab, and operates as a for-profit entity with international backing.

Therapeutic areas: Cardiovascular
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on VAP Diagnostics Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VAP Diagnostics Lab.

Explore the full profile